Digoxin



Compound IDCDAMM00788
Common nameDigoxin
IUPAC name3-[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
Molecular formulaC41H64O14

Experimental data

Retention time15.57
Adduct[M+H]+
Actual mz781.439
Theoretical mz781.437
Error2.72
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2077

Identifiers and class information

Inchi keyLTMHDMANZUZIPE-PUGKRICDSA-N
SmilesO=C1OCC(=C1)C2CCC3(O)C4CCC5CC(OC6OC(C)C(OC7OC(C)C(OC8OC(C)C(O)C(O)C8)C(O)C7)C(O)C6)CCC5(C)C4CC(O)C23C
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)9
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)780.948
Computed dipole moment(dipole)10.767
Total solvent accessible surface area (SASA)1030.08
Hydrophobic component of SASA (FOSA)740.807
Hydrophilic component of SASA (FISA)260.642
Pie component of the SASA (PISA)28.635
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2146.47
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)22.45
Free energy of solvation of dipole (dip^2/V)0.0540054
Index of cohesive interaction in solids (ACxDN^.5/SA)0.053385
Globularity descriptor (glob)0.781225
Predicted polarizability in cubic angstroms (QPpolrz)72.316
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.24
Predicted octanol/gas partition coefficient (QPlogPoct)46.347
Predicted water/gas partition coefficient (QPlogPw)32.419
Predicted octanol/water partition coefficient (QPlogPo/w)1.164
Predicted aqueous solubility (QPlogS)-4.956
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.996
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.209
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)33.437
Predicted brain/blood partition coefficient (QPlogBB)-3.007
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)12.567
Predicted skin permeability, log Kp (QPlogKp)-5.07
PM3 calculated ionization potential (IP(ev))10.509
PM3 calculated electron affinity (EA(eV))0.874
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-0.459
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)22.166
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)198.406
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P51449RORCNuclear receptor ROR-gammaT25307SwissTargetPrediction and SEA
P40763STAT3Signal transducer and activator of transcription 3T29130SwissTargetPrediction
P05023ATP1A1Sodium/potassium-transporting ATPase alpha-1 chainT40800SwissTargetPrediction and SEA
O15399GRIN2DGlutamate [NMDA] receptor subunit epsilon 4T56588SEA
Q14957GRIN2CGlutamate receptor ionotropic NMDA 2CT72595SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T25307DI0042Autoimmune disease[ICD-11: 4A40-4A45]P51449RORC
T25307DI0107Crohn disease[ICD-11: DD70]P51449RORC
T25307DI0238Lung cancer[ICD-11: 2C25]P51449RORC
T25307DI0275Multiple sclerosis[ICD-11: 8A40]P51449RORC
T25307DI0351Psoriasis[ICD-11: EA90]P51449RORC
T25307DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P51449RORC
T29130DI0351Psoriasis[ICD-11: EA90]P40763STAT3
T40800DI0068Cardiac arrhythmia[ICD-11: BC9Z]P05023ATP1A1
T40800DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P05023ATP1A1
T40800DI0101Corneal disease[ICD-11: 9A76-9A78]P05023ATP1A1
T40800DI0175Heart failure[ICD-11: BD10-BD1Z]P05023ATP1A1
T40800DI0186Hyperhidrosis[ICD-11: EE00]P05023ATP1A1
T40800DI0243Malaria[ICD-11: 1F40-1F45]P05023ATP1A1
T40800DI0397Supraventricular tachyarrhythmia[ICD-11: BC81]P05023ATP1A1
T56588DI0296Neurodegenerative disorder[ICD-11: 8A20-8A23]O15399GRIN2D
T72595DI0296Neurodegenerative disorder[ICD-11: 8A20-8A23]Q14957GRIN2C

Copyright © 2025